The OBR Video Center Features educational videos covering a wide range of oncology specific topics.
Dr. Popplewell, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Hematologist/Oncologist, City of Hope, describes how engineered toxin bodies (EBTs) work as an anti-cancer treatment
Tags: ASH Conference Coverage
Published: 16 December 2020
Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists
Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, considers the progress being made at the community ...
Johnetta Blakely, MD, offers an example of how HEOR has impacted cancer care at Tennessee Oncology
Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, offers a case example of how real-world evidence ...
Johnetta Blakely, MD, elaborates on how HEOR may be used in conjunction with real-world evidence
Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, elaborates on how health economics outcomes research (HEOR) ...
Johnetta Blakely, MD, considers how HEOR data influences payer decisions
Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, considers how health economics and outcomes research (HEOR) ...
Johnetta Blakely, MD, explains the role of HEOR as it contributes to value-based care
Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, explains the role of health economics outcomes research ...
Jonathan E. Levitt, Esq., considers how PBM behaviors are changing as a result of the pandemic
Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, considers how pharmacy benefit manager (PBM) behaviors are changing as a result ...
Jonathan E. Levitt, Esq., offers opinion on PBM consolidation & the changing dynamics of cancer care
Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, offers opinion on PBM consolidation and the changing dynamics of cancer care
Jonathan E. Levitt, Esq., explains how copay aggregators differ across PBMs
Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, explains how copay aggregators differ across PBMs
Jonathan E. Levitt, Esq., on the experience of hem/onc groups unable to enter into a PBM network
Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, considers the experience of hematology/oncology groups who are unable to enter into a ...
Jonathan E. Levitt, Esq., explains how DIR fees impact practice costs and efficiencies
Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, explains how DIR fees impact practice costs and efficiencies
Follow @OBRTweets